Argi Investment Services, LLC Biogen Inc. Transaction History

Argi Investment Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $211,066 - $279,520	-816 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$268.85 - $341.04 $42,747 - $54,225	-159 Reduced 16.31%	816 $258,000
Q4 2019 Feb 11, 2020	SELL	$220.06 - $304.07 $16,284 - $22,501	-74 Reduced 7.05%	975 $330,000
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $13,481 - $15,120	-62 Reduced 5.58%	1,049 $244,000
Q2 2019 Aug 13, 2019	BUY	$219.29 - $241.72 $35,963 - $39,642	164 Added 17.32%	1,111 $260,000
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $205,224 - $320,995	947 New	947 $224,000

998

130M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Argi Investment Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Argi Investment Services, LLC with notifications on news.